ADIAL PHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q3 2018 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Adial Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2018 to Q2 2024.
  • Adial Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 12, 2024 was 6.4M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 6.4M Aug 12, 2024 10-Q 2024-08-13
Q1 2024 4.05M -24.5M -85.8% Mar 29, 2024 10-K 2024-04-01
Q3 2023 1.22M -25.6M -95.5% Nov 9, 2023 10-Q 2023-11-14
Q1 2023 28.5M +4.8M +20.2% Mar 30, 2023 10-K 2023-03-30
Q3 2022 26.9M +6.09M +29.3% Nov 14, 2022 10-Q 2022-11-14
Q2 2022 25.9M +5.56M +27.4% Aug 12, 2022 10-Q 2022-08-15
Q1 2022 23.7M +6.45M +37.3% Mar 23, 2022 10-K 2022-03-28
Q3 2021 20.8M +6.55M +46.1% Nov 12, 2021 10-Q 2021-11-15
Q2 2021 20.3M +6.74M +49.7% Aug 12, 2021 10-Q 2021-08-12
Q1 2021 17.3M +6.79M +64.8% Mar 22, 2021 10-K 2021-03-22
Q3 2020 14.2M +3.9M +37.8% Nov 13, 2020 10-Q 2020-11-13
Q2 2020 13.6M +3.32M +32.4% Aug 13, 2020 10-Q 2020-08-13
Q1 2020 10.5M +260K +2.54% Mar 20, 2020 10-K 2020-03-20
Q3 2019 10.3M +3.76M +57.4% Nov 14, 2019 10-Q 2019-11-14
Q2 2019 10.2M Aug 13, 2019 10-Q 2019-08-13
Q1 2019 10.2M May 13, 2019 10-Q 2019-05-13
Q3 2018 6.56M Sep 6, 2018 10-Q 2018-09-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.